Myomo Inc
$ 0.78
-4.83%
23 Apr - close price
- Market Cap 31,552,600 USD
- Current Price $ 0.78
- High / Low $ 0.80 / 0.76
- Stock P/E N/A
- Book Value 0.30
- EPS -0.37
- Next Earning Report 2026-05-06
- Dividend Per Share N/A
- Dividend Yield 0 %
- Next Dividend Date -
- ROA -0.22 %
- ROE -0.86 %
- 52 Week High 4.99
- 52 Week Low 0.60
About
Myomo, Inc., a portable medical robotics company, designs, develops and produces myoelectric braces for people with neuromuscular disorders in the United States. The company is headquartered in Boston, Massachusetts.
Analyst Target Price
$4.32
Quarterly Earnings
| Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 | Sep 2023 | Jun 2023 | Mar 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Reported Date | 2026-03-16 | 2025-11-10 | 2025-08-11 | 2025-05-06 | 2025-03-05 | 2024-11-06 | 2024-08-06 | 2024-05-08 | 2024-03-07 | 2023-11-07 | 2023-08-09 | 2023-05-10 |
| Reported EPS | -0.0852 | -0.09 | -0.12 | -0.08 | -0.01 | -0.03 | -0.03 | -0.1 | -0.07 | -0.06 | -0.04 | -0.11 |
| Estimated EPS | -0.084 | -0.11 | -0.1 | -0.1 | -0.0233 | -0.04 | -0.07 | -0.1 | -0.06 | -0.09 | -0.03 | -0.13 |
| Surprise | -0.0012 | 0.02 | -0.02 | 0.02 | 0.0133 | 0.01 | 0.04 | 0 | -0.01 | 0.03 | -0.01 | 0.02 |
| Surprise Percentage | -1.4286% | 18.1818% | -20% | 20% | 57.0815% | 25% | 57.1429% | 0% | -16.6667% | 33.3333% | -33.3333% | 15.3846% |
Next Quarterly Earnings
| Mar 2026 | |
|---|---|
| Reported Date | 2026-05-06 |
| Fiscal Date Ending | 2026-03-31 |
| Estimated EPS | -0.12 |
| Currency | USD |
Next Dividend Records
| Dividend per share (year): | - |
| Dividend Yield | - |
| Next Dividend Date | - |
| Ex-Dividend Date | - |
Recent News: MYO
2026-04-21 05:10:24
Myomo, Inc. has launched a new mobile app for its MyoPro robotic orthosis, aimed at enhancing the experience for both patients with upper-limb paralysis and their clinicians. The app allows real-time EMG signal visualization, remote configuration adjustments, and improved patient-clinician collaboration, bridging hardware and digital health. This strategic move aims to empower patients, streamline clinical workflows, and gather valuable data to support reimbursement claims and future product development.
2026-04-20 22:10:24
Myomo (MYO) has launched the Myomo Mobile App, a new digital tool designed to enhance the MyoPro experience for both clinicians and patients. The app aims to simplify device configuration and improve patient usage visibility for clinicians, while providing real-time feedback and training resources to patients. The Myomo Mobile App is now available on both the Google Play Store and Apple App Store.
2026-04-20 22:10:24
Myomo Inc. has launched a new mobile app for its MyoPro upper-limb orthosis, designed to enhance device management for both clinicians and patients. The app enables clinicians to customize settings remotely and monitor patient usage, while patients can visualize muscle activity, track repetitions, and access training resources. Despite challenging market conditions, Myomo reported 26% revenue growth over the last year, and its stock appears undervalued according to InvestingPro analysis.
2026-04-20 20:34:11
Myomo Inc. has introduced the Myomo Mobile App for users of its MyoPro upper-limb orthosis, allowing clinicians to remotely customize device settings and monitor patient usage. The app also provides patients with real-time muscle activity visualization, repetition tracking, and access to training materials. This launch follows Myomo's 26% revenue growth, and the stock is considered undervalued by InvestingPro analysts despite the company's cash burn.
2026-04-20 20:09:11
Myomo, Inc. (NYSE American: MYO) has launched the Myomo® Mobile App to improve the MyoPro® experience for both clinicians and patients. The app provides clinicians with a streamlined interface for customizing EMG settings and monitoring patient usage, while offering patients real-time muscle activity insights and access to training resources. This development aims to make MyoPro care more intuitive, connected, and data-informed, reinforcing Myomo's commitment to enhancing the user experience.
2026-04-16 20:39:53
MYOMO, Inc. Director William J. Febbo was granted 45,000 restricted stock units (RSUs) as equity compensation under the company's 2018 Stock Option and Incentive Plan. This grant, valued at $0.00 per share, vests entirely on the first anniversary of the grant date. Following this transaction, Febbo's direct beneficial ownership of MYOMO shares totals 45,000.
